SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GENSET - GENXY
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who wrote (63)4/20/2000 11:24:00 AM
From: Mike McFarland   of 200
 
"During this quarter, Genset strengthened its business and research activities in its different priority areas. "

-- Central Nervous System diseases

Genset and Abbott Laboratories signed a new research
agreement to discover genes associated with bipolar
disease.

-- Metabolic disorders

Genset signed a research collaboration with the Whitehead
Institute on obesity and diabetes. Genset was also granted
the exclusive license on the patent covering
ACRP30 a protein associated with obesity.

-- Other research activities

Genset reached an important milestone in its research
agreement with the plant genomics company Ceres.

Genset signed a research agreement with Corixa to sequence
an undisclosed microorganism.

-- Oligonucleotide division
Genset continued its geographical expansion and opened a
new subsidiary in Australia.
____________________________________

If anybody is interested...I'll save you the effort
of googlizing ACRP30...

Harvey Lodish, Ph.D. to join Genset Scientific Advisory Board
genxy.com
web.mit.edu
or if you prefer your ACRP30 without the typo,
but a horrible background...
syntermedia.com

J Cell Biol 1999 Aug 9;146(3):609-20
Two compartments for insulin-stimulated exocytosis
in 3T3-L1 adipocytes defined by endogenous ACRP30
and GLUT4.
Bogan JS, Lodish HF
ncbi.nlm.nih.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News